Drugs / ALH-L1005
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04503746 | Jul 2020 → Dec 2021 | chronic periodontitis | AngioLab, Inc. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ALH-L1005 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04503746 ↗ |